Home › Essential Thrombocythemia › Florida › Miami
Essential Thrombocythemia clinical trials in Miami, FL
4 studies for Essential Thrombocythemia are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RecruitingPhase 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
RecruitingPhase 3
- University of Miami Sylvester Comprehensive Cancer Center, Miami
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- University of Miami, Miami
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- University of Miami Health System, Miami
Essential Thrombocythemia trials in other cities
- New York City, NY7 studies
- Durham, NC6 studies
- Boston, MA4 studies
- Chicago, IL4 studies
- Baltimore, MD4 studies
- Mountain View, CA4 studies
- Salt Lake City, UT4 studies
- Los Angeles, CA3 studies
- St. Louis, MO3 studies
- Cleveland, OH3 studies
- Nashville, TN3 studies
- Kansas City, MO3 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer31 studies
- Prostate Cancer27 studies
- Obesity27 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
- Metastatic Cancer23 studies
- Overweight23 studies
- Ulcerative Colitis22 studies
- Alzheimer's Disease21 studies
- Multiple Myeloma21 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.